A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are also rapidly advancing vaccine development. These efforts aim to combat the fast-growing outbreak. The vaccines utilize established technology for quicker production. International partners are collaborating to scale up manufacturing and response measures.

The new Ebola outbreak highlights market failures that hinder vaccine research and response to neglected tropical diseases.

Amid the Ebola virus outbreak, India on Monday reviewed its own preparedness and surveillance systems. | India News

The vaccine, which hasn’t been tested on humans, would be the first capable of treating the deadly Bundibugyo strain of Ebola.

She said the outbreak involves a rare strain of the Ebola virus and has been difficult to detect early due to limitations in existing diagnostic tools, which were primarily…

⚡️⚡️ Russian scientists have developed a vaccine against a new #Ebola strain, Health Minister #Murashko announcedAccording to the Russian scientists, the vaccine may also protect…

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are…

Production of an experimental Ebola vaccine from the developers of a Covid-19 shot is expected to begin soon, with animal studies...